Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar EclecticRecluse (77.78) Submitted: 5/5/2011 4:31:17 AM : Underperform Start Price: $36.88 ONXX Score: -28.37

Earnings Estimates Revised Downward

Featured Broker Partners


Advertisement